The study show that the motion therapy device(Innowalk) have direct effect on the hip joint of children with CP. Effects on the range of motion and mucle tone was documented. Duration of the intervention (3 months) was a determining factor.
Evaluation on gait and gastrointestinal function in a 13 year old child with CP GMFCS III. Improvements was seen in range of motion on the hip, gastrointestinal function, resistance against rapid passive stretch, and walking function.
for dosing of pediatric supported standing programs